<--- Back to Details
First PageDocument Content
Orthomolecular medicine / Viral diseases / Coenzymes / Organic acids / Picornaviruses / Rhinovirus / Common cold / Vitamin C / Ascorbic acid / Medicine / Alternative medicine / Chemistry
Date: 2009-08-13 04:29:42
Orthomolecular medicine
Viral diseases
Coenzymes
Organic acids
Picornaviruses
Rhinovirus
Common cold
Vitamin C
Ascorbic acid
Medicine
Alternative medicine
Chemistry

Antibiotics have no place in the treatment of uncomplicated colds, and antihistamines have only a minimal effect in reducing nasal secretions[removed]Until truly effective and specific treatment becomes available, there w

Add to Reading List

Source URL: www.mv.helsinki.fi

Download Document from Source Website

File Size: 33,78 KB

Share Document on Facebook

Similar Documents

Best Maid Snickerdoodle 1

Best Maid Snickerdoodle 1

DocID: 1roug - View Document

Seminar 1, Tuesday 8/3  Material and energy budget  1.​  In his studies of glycolysis in cancer, Otto Warburg noted that some tumors produce their own  weight in lactate in as little as 

Seminar 1, Tuesday 8/3  Material and energy budget  1.​  In his studies of glycolysis in cancer, Otto Warburg noted that some tumors produce their own  weight in lactate in as little as 

DocID: 1rmhs - View Document

ACTA VET. BRNO 2015, 84: 43–46; doi:avb201585010043  Coenzyme Q 10 – its biochemical and related aspects Vladimír Kopřiva1, Petr Dvořák1, Jana Pokorná2, Michal Žďárský1 1

ACTA VET. BRNO 2015, 84: 43–46; doi:avb201585010043 Coenzyme Q 10 – its biochemical and related aspects Vladimír Kopřiva1, Petr Dvořák1, Jana Pokorná2, Michal Žďárský1 1

DocID: 1rkRi - View Document

Nutrition / Chemistry / Biology / Physiology / Vitamins / Coenzymes / B vitamins / Magnesium in biology / Vitamin C / Hydroxocobalamin / Tocopherol / MG Cars

NEURAL PROTOCOL INGREDIENTS I. Glutathione By Nebulizer Beginning at 30 mg/ml, 4cc/d and working up as tolerated to 100 mg/cc or more (up to 200 mg/cc) 4cc/d or more. If irritation at 30 mg/cc dilute further with norma

DocID: 1rb5f - View Document

Quartet Medicine Announces Strategic Partnership with Merck -- Agreement provides non-dilutive research and development funding to advance novel pain treatments in exchange for exclusive option -CAMBRIDGE, Mass.– Janua

Quartet Medicine Announces Strategic Partnership with Merck -- Agreement provides non-dilutive research and development funding to advance novel pain treatments in exchange for exclusive option -CAMBRIDGE, Mass.– Janua

DocID: 1r88c - View Document